rBIO, a biotech startup based in Houston, has innovated a new process for producing biosimilar insulin using custom-engineered bacteria, aiming to significantly reduce the costs of insulin production and make it more affordable for millions.

Basic information

Country

USA

Group Name

rBIO

Source

Source